Evidence map›Paper›PMID 27129290›Full record

ArticleBioscience reports2016

Resveratrol ameliorates renal injury in spontaneously hypertensive rats by inhibiting renal micro-inflammation.

Hai-Yan Xue, Li Yuan, Ying-Jie Cao, Ya-Ping Fan, Xiao-Lan Chen, Xin-Zhong Huang

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Hirudin Ameliorates Renal Interstitial Fibrosis via Regulating TGF-Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Anti-Renal Fibrotic Effect of Exercise Training in Hypertension.International journal of molecular sciences · 2018
    Article
  18. JYYS Granule Mitigates Renal Injury in Clinic and in Spontaneously Hypertensive Rats by Inhibiting NF-Evidence-based complementary and alternative medicine : eCAM · 2018
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hai-Yan XueDepartment of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China.
Li YuanDepartment of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China.
Ying-Jie CaoDepartment of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China.
Ya-Ping FanDepartment of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China.
Xiao-Lan ChenDepartment of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China chenxl8448@sina.com huangxz421@126.com.
Xin-Zhong HuangDepartment of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China chenxl8448@sina.com huangxz421@126.com.
Affiliated Hospital of Nantong University · CNNantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Micro-inflammation plays an important role in the pathogenesis of spontaneously hypertensive rat (SHR). In the present study, we investigated the therapeutic potential of resveratrol (RSV), a polyphenol with anti-fibrosis activity in hypertensive renal damage model. In SHR renal damage model, RSV treatment blunted the increase in urine albumin excretion, urinary β2-microglobulin (β2-MG), attenuated the decrease in creatinine clearance rate (CCR). The glomerular sclerosis index (1.54±0.33 compared with 0.36±0.07) and tubulointerstitial fibrosis (1.57±0.31 compared with 0.19±0.04) were significantly higher in SHRs compared with Wistar Kyoto rats (WKYs), which were significantly lower by RSV treatment. The increases in mesangium accumulation and the expression of renal collagen type I (Col I), fibronectin (Fn), plasminogen activator inhibitor-1 (PAI-1) and transforming growth factor-β1 (TGF-β1) in SHR were also reduced by RSV treatment. Nuclear factor κB (NF-κB) expression was increased in the cytoplasm and nuclei of the SHR kidneys, which was significantly decreased by RSV treatment. Furthermore, the protein level of IκB-α significantly decreased in the kidneys of the SHR when compared with the WKYs. RSV treatment partially restored the decreased IκB-α level. In SHR kidney, increased expression of interleukin-6 (IL-6), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein 1 (MCP-1) were observed. These changes were attenuated by RSV treatment. No changes in blood pressure were detected between SHR group and SHR + RSV group. Taken together, the present study demonstrated that RSV treatment may significantly attenuate renal damage in the SHR model of chronic kidney disease (CKD). The renal protective effect is associated with inhibition of IL-6, ICAM-1 and MCP-1 expression via the regulation of the nuclear translocation of NF-κB, which suggesting that micro-inflammation may be a potential therapeutic target of hypertensive renal damage.

Indexed as

Acute Kidney InjuryAnimalsbeta 2-MicroglobulinBlood PressureCollagen Type IDisease Models, AnimalFibronectinsFibrosisGene Expression RegulationHumansHypertensionInflammationKidneyPlasminogen Activator Inhibitor 1RatsResveratrolbeta 2-MicroglobulinCollagen Type IFibronectinsPlasminogen Activator Inhibitor 1ResveratrolStilbenesTgfb1 protein, ratTransforming Growth Factor beta1inflammationintercellular adhesion molecule-1 (ICAM-1)interleukin-6 (IL-6)monocyte chemoattractant protein 1 (MCP-1)nuclear factor κB (NF-κB)resveratrol (RSV)spontaneously hypertensive rat (SHR)

Identifiers

PMID27129290
PMCPMC5293588
OpenAlexW2338876467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.